REFERENCES
- Ruble J. Off-label prescribing of medications for pain: maintaining optimal care at an intersection of law, public policy and ethics. J Pain Palliat Care Pharmacother. 2012;26:xx–xx.
- Wilkes MS, Bell RA, Kravitz Rl. Direct to consumer prescription drug advertising: trends, impact and implications. Health Affairs. 2000;19:110–128.
- Kesselheim AS, Mello MM, Studdert DM. Strategies and practices in off-label marketing of pharmaceuticals: a retrospective analysis of whistleblower complaints. PLoS Med. 2011;8:e1000431. doi: 101371 /journal.pmed.1000431.
- Latham SR. Speaking off label. Hastings Center Rep. 2010;40:9–10.
- Institute of Medicine. Relieving Pain in America—A Blueprint for Transforming Prevention, Care, Education and Research. Washington, DC: National Academies Press; 2011.
- The American Pain Society in Conjunction with the American Academy of Pain Medicine. Clinical Guideline for the Use of Opioid Therapy in Chronic Noncancer Pain—Evidence Review. American Pain Society; 2009. Available at: http//www.ampainsoc.org/library/pdf/Opioid_Final_Evidence_Report.pdf.
- Federal Drug Administration. Good reprint practices for the distribution of medical journal articles and medical or scientific reference publications on unapproved new uses of approved drugs and approved or cleared medical devices. 2009. Available at: http://www.fda.gov/RegulatoryInformation/Guidances/ucm125126htm. Accessed March 17, 2012.
- Georgetown University Woodstock Center. Principles for the ethical conduct of lobbying. 2009. Available at: http://woodstock.georgetown.edu/resources/papers/papers-Principles- For-Ethical-Lobbying.html. Accessed March 17, 2012.
- Dresser R, Frader J. Off-label prescribing: a call for heightened professional and government oversight. J Law Med Ethics. 2009;37:476–486.
- Johns MZ. Informed consent: requiring doctors to disclose off-label prescriptions and conflicts of interest. Hastings Law J. 2007;58:967–1024.
- Ethics and Human Rights Committee: American College of Physicians. Ethics Manual. Ann Intern Med. 2005;142:560–582.
- Radley DC, Finkelstein SN, Stafford RS. Off-label prescribing among office-based physicians. Arch Intern Med. 2006;166:1021–1026.
- Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ. 2001;323:334–336.
- Largent EA, Miller FG, Pearson SD. Going off-label without venturing off course. Arch Intern Med. 2009;169:1745–1747.